BIOS — Biosenic SA Share News
0.000.00%
Last trade - 00:00Brief: Bone Therapeutics Anticipates Cash Runway Until End Of Q1 2022
Brief: Bone Therapeutics Appoints Scientific Advisory Board
Brief: Bone Therapeutics Signs Partnership With Implant Therapeutics
Brief: Bone Therapeutics Appoints Lieve Creten As Interim CFO
Brief: Bone Therapeutics H1 Operating Loss Narrows To EUR 5.72 Mln
Brief: Bone Therapeutics Reacts To Hybrigenics Press Release
Brief: Hybrigenics Renews Proposal For Synergies Discussions With Bone Therapeutics
Bone Therapeutics heads for worst day ever on trial failure
Brief: Bone Therapeutics Gets EIB's Disbursement Offer For EUR 8 Mln Tranche
Brief: Bone Therapeutics Says JTA Efficacy Results Are Disappointing
Brief: FSMA Reports Agreed Settlement With Bone Therapeutics
Brief: Bone Therapeutics Says ALLOB Clinical Study On Track But Recruitment Slow
Brief: -Bone Therapeutics Secures Up To EUR 16 Mln Loan Financing From EIB
Brief: Bone Therapeutics Posts Positive Results Of ALLOB Study
Brief: Bone Therapeutics Net Cash At End-March Amounts To EUR 8.5 Million
Brief: Bone Therapeutics FY Net Loss Widens To 11.9 Mln
Brief: Bone Therapeutics Appoints Anthony Ting As Chief Scientific Officer
Brief: Bone Therapeutics: Sufficient Cash To Carry Out Business Objectives Until End Q4 2021
Brief: Bone Therapeutics, Rigenerand Partner On Cell Therapy